PRLR-SLICK Cattle by is a Other medication manufactured, distributed, or labeled by Recombinetics, Inc., Acceligen, Inc.. Drug facts, warnings, and ingredients follow.
Identity: CRISPR-Cas9 editing with or without homology dependent repair in heat-susceptible beef breeds to introduce mutations into at least one copy of the PRLR gene of Bos taurus chromosome 20 (NC_037347.1). The intended mutations generate a premature stop codon in the coding sequence resulting in a truncated PRLR protein and a SLICK coat phenotype.
Product Use: Founder animals are intended for production and sale of seed stock and/or embryos to enable the establishment of PRLR-SLICK thermotolerant beef herds that will be used as a food source. Due to the specific process used to produce these animals, they may have 2 or more genetically different sets of cells, and as a result the PRLR-SLICK thermotolerant phenotype may not be inherited by all first generation progeny.
PRLR-SLICK CATTLE
prlr gene edit in at least one copy producing protein truncation at or between amino acids 433 to 497 not applicable |
|||||||||||||||
|
|||||||||||||||
|
|||||||||||||||
|
|||||||||||||||
|
Labeler - Recombinetics, Inc. (829874523) |
Registrant - Acceligen, Inc. (108237218) |
Establishment | |||
Name | Address | ID/FEI | Business Operations |
---|---|---|---|
Recombinetics, Inc. | 829874523 | manufacture |